http://www.law360.com/ Latest articles for organization: Katten Muchin Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/134494 A federal judge has reserved his ruling on Honeywell International Inc.’s bid to dismiss bid-rigging allegations brought by its former distributor Integrated Systems and Power Inc. after hearing the parties’ arguments on Friday over competition in the fire-detection and alarm system market in New York City. http://www.law360.com/articles/134494 http://www.law360.com/articles/135379 Retalix Ltd. has quickly snuffed a putative shareholder class action accusing the software company and its directors of agreeing to a lopsided $32.9 million share purchase agreement with a group of investors. http://www.law360.com/articles/135379 http://www.law360.com/articles/134513 First Banks Inc. subsidiary First Bank plans to sell its Chicago franchise, which holds deposits valued at $1.2 billion, to FirstMerit Bank NA for $42 million as part of continued plans to raise capital in response to the economic downturn. http://www.law360.com/articles/134513 http://www.law360.com/articles/133027 Commercial real estate developers increasingly find themselves within the emerging trend of green building, but many Midwestern developers hesitate to commit to environmentally friendly goals because of the sensed sizeable increase in startup costs for new buildings. Such fears, however, are misguided, says Michael J. Lusardi of Katten Muchin Rosenman LLP. http://www.law360.com/articles/133027 http://www.law360.com/articles/133121 Axis Reinsurance Co. has asked a federal judge to reconsider its motion for summary judgment on a former Refco Inc. vice president’s demand for an additional $7.5 million in settlement fees on top of $10 million the insurer already shelled out to cover defense costs. http://www.law360.com/articles/133121 http://www.law360.com/articles/131977 Calling the inquiries “irrelevant and inappropriate,” Sanofi-Aventis SA and Bristol-Myers Squibb Co. have sought to snuff out six subpoenas issued by generic-drug maker Apotex Inc. in connection with settlement amount determinations in a patent infringement dispute over blockbuster blood thinner Plavix. http://www.law360.com/articles/131977 http://www.law360.com/articles/130656 Purdue Pharma LP has resolved a patent dispute with Apotex Inc. that was tied into the multidistrict litigation alleging Purdue engaged in sham patent infringement litigation to keep generic companies from making copycat versions of painkiller OxyContin. http://www.law360.com/articles/130656 http://www.law360.com/articles/130197 Five Midway Games Inc. executives are off the hook in a suit accusing them of selling off millions of dollars of artificially inflated stock in 2005 to the detriment of a putative class of shareholders. http://www.law360.com/articles/130197 http://www.law360.com/articles/129645 Taxpayers are unlikely to see the full return of the nearly $700 billion allocated to the Troubled Asset Relief Program, and the injection of government funds into insolvent businesses risks reinforcing the corporate behavior that led to the financial crisis, a government report said Wednesday. http://www.law360.com/articles/129645 http://www.law360.com/articles/121273 One of the biggest issues for clients now is the fact that the United States considers China a "nonmarket economy" for purposes of calculating anti-dumping duty margins, says Mark S. Zolno, founder and chairman of Katten Muchin Rosenman LLP’s customs and international trade practice. http://www.law360.com/articles/121273 http://www.law360.com/articles/128671 Reassuring the secondary loan market, the New York Court of Appeals has issued a ruling clarifying the limits of the state's arcane champerty law, ruling that the age-old law with roots in medieval Europe was not designed to curb the ability of buyers of distressed debt to enforce their rights through litigation and collect on a legitimate claim. http://www.law360.com/articles/128671 http://www.law360.com/articles/121271 A party’s right to discovery should be better balanced against what is actually relevant under the circumstances and what any related discovery may cost, says Mary Ellen Hennessy, a partner with Katten Muchin Rosenman LLP who focuses on antitrust litigation. http://www.law360.com/articles/121271 http://www.law360.com/articles/126491 The U.S. Supreme Court has declined to hear an appeal of a $4.2 million verdict handed down against a lawyer and a former State Farm Mutual Automobile Insurance Co. claims representative who were accused of colluding to bilk the insurance company of millions of dollars by making “excessive payments” to the lawyer and his clients. http://www.law360.com/articles/126491 http://www.law360.com/articles/126342 Generic-drug maker Apotex Corp. has launched a new attack on Bristol-Myers Squibb Co. and Sanofi-Aventis' patent for blood-thinning drug Plavix, arguing in a new suit that it is unenforceable because Bristol-Myers and Sanofi breached a 2006 settlement with Apotex over the patent. http://www.law360.com/articles/126342 http://www.law360.com/articles/126040 A bankruptcy judge has signed off on a $1.4 million settlement in an antitrust suit brought by bankrupt auto parts supplier Visteon Corp. against French carbon and graphite company Le Carbone Lorraine SP, which has pled guilty to price-fixing allegations from U.S., European and Canadian officials. http://www.law360.com/articles/126040 http://www.law360.com/articles/126060 Thanks to an upswing in demand for its core practice areas, Katten Muchin Rosenman LLP has asked six members of its first-year associate class of 2009 — whose group start date previously had been pushed back until 2010 — to report for work this month. http://www.law360.com/articles/126060 http://www.law360.com/articles/123729 The upcoming decision by New York’s highest court in a case that probes the boundaries of the state’s champerty law could have a dramatic impact on the multibillion-dollar commercial mortgage-backed securities market still reeling in the wake of the financial crisis, attorneys say. http://www.law360.com/articles/123729 http://www.law360.com/articles/125261 A federal judge has denied class certification to a group of nurses who had sued four separate hospital systems in the greater Chicago area on allegations that the institutions colluded to suppress their wages in violation of antitrust law. http://www.law360.com/articles/125261 http://www.law360.com/articles/124883 Eisai Co. Ltd. has asked a federal court to dismiss Apotex Inc.’s declaratory judgment action over four patents covering Eisai’s Alzheimer’s drug Aricept, arguing that Apotex is using the suit to try to jump ahead of competitors in the approval process to market the generic drug. http://www.law360.com/articles/124883 http://www.law360.com/articles/122810 AstraZeneca Plc has asked a federal court for a ruling in its favor in a nearly 2-year-old patent infringement litigation the pharmaceutical giant has been pursuing against several generic-drug makers over its cholesterol drug Crestor. http://www.law360.com/articles/122810